General Mills Debate over GMOs

 

 

General Mills Inc. struck down a proposal to ban GMOs (Genetically Modified Organisms) as ingredients from all their brands last week at their annual shareholder meeting. A resounding 98 percent of shareholders voted against a companywide ban. The definitive decision comes as somewhat of a surprise because of the company’s recent removal of GMOs from its Cheerios cerea…

Igenbio and Genome Compiler Corp. Enter into a Collaborative Agreement to Offer Synthetic Biology Solutions

Chicago, Illinois and Los Altos, CA (Aug 3, 2014). Igenbio. Inc a, Chicago based genome analysis company announced today they entered into a collaborative agreement with Genome Compiler Corp., a Los Altos based synthetic biology software company. Igenbio and Genome Compiler are partnering to create comprehensive synthetic biology solutions. Igenbio Japan will be promoting and distributing its…

Leading Scientists Address Congress on Future of Synthetic Biology

Dr. Karmella Haynes, an assistant professor from Arizona State University, was among a small group of scientists who addressed a recent Congressional hearing about the emerging field of Synthetic Biology. In the Haynes Lab at the ASU School of Biological and Health Systems Engineering, Dr. Haynes is currently involved in synthetic biology research in the hopes of solving some of the world’s…

Playing the China Card with Genetic Testing

The Chinese Food and Drug Administration have just opened a huge new market for a revolutionary, essentially risk-free prenatal test for the three most common genetic diseases. The NIFTY test, designed by the Beijing Genomics Institute, is a simple, highly accurate, and non-invasive test that is now available to millions of Chinese women.
 The NIFTY test requires a mere 10ml of a mother’s…

Debug your project with a single click. Compilation Design Rules Engine now streamlines common and synthesizer specific design rules.

Genome Compiler’s new Compilation Design Rules Engine allows for users to now ensure that their projects follow nature’s engineering constraints as well specific rules from the industry’s most prominent synthesizers. Also look forward for future releases to establish your own design constraints as well. Debugging complex synthetic biology work has never been easier.
Features such as t…

The Wall Street Journal checks in with the “revolutionary” Glowing Plant

The progress of Glowing Plant, one of Genome Compiler’s flagship synbio partners and personal undertaking of Genome Compiler CEO Omri Amriav-Dory (as strategic adviser), has once again piqued the interest of the Wall Street Journal. In a series of recent blog articles and online videos, Wall Street Journal’s Deborah Kan has interviewed Glowing Plant’s CEO Antony Evans concerning the genetic…

Genome Compiler is available right in your browser, try the demo today

We are excited to announce our new online demo of Genome Compiler, available just a few clicks away directly within your web browser! Now you can experience the basics of Genome Compiler’s powerful abilities without as much as a download.

Get to know Genome Compiler’s innovative user interface and intuitive tools for efficient and flexible work. Move around to see what dynamic features ar…

Synthetic biology’s next step? New artificial nuelotides can change the basics

This week, the synthetic biology community is excited to add two new materials to its genetic toolbox. Researchers at The Scripps Research Institute of La Jolla, California have announced the successful synthesis of two entirely synthetic nucleobases with the ability of incorporating the new proteins into the DNA of E. Coli bacteria.

These breakthrough findings effectively increase t…

What 80 Biologists Working on the First Synthetic Yeast Chromosome Wish they had

With the most recent triumph of developing the world’s first completely synthetic eukaryotic chromosome under the leadership of Dr. Jef Boeke’s Johns Hopkins lab it is clear that ambitions within the field of Synthetic Biology are growing larger every day. With these incredible undertakings come larger sequences, and with these larger sequences come larger teams manipulating larger selections…

Resolved: The Patent that has been Bugging the Synthetic Biology Software Community

Genome Compiler is happy to confirm that the litigation between DNA2.0 and GCC has been settled. As part of the settlement, DNA2.0 has granted GCC a worldwide license, covering GCC, it’s customers and it’s users.

Read more analysis on the subject from a  third party perspective .

Read Official Settlement here.

Pictur…

Copyright © Genome Compiler 2014. All Rights Reserved.